Sorption of the antibiotic ofloxacin to mesoporous and nonporous alumina and silica.
Mesoporous and nonporous SiO(2) and Al(2)O(3) adsorbents were reacted with the fluoroquinolone carboxylic acid ofloxacin over a range of pH values (2-10) and initial concentrations (0.03-8 mM) to investigate the effects of adsorbent type and intraparticle mesopores on adsorption/desorption. Maximum ofloxacin adsorption to SiO(2) surfaces occurs slightly below the pK(a2) (pH 8.28) of the antibiotic and sorption diminishes rapidly at pH>pK(a2). For Al(2)O(3), maximum sorption is observed at pH values slightly higher than the adsorbent's point of zero net charge (p.z.n.c.) and less than midway between the pK(a) values of ofloxacin. The effects of pH on adsorption and ATR-FTIR spectra suggest that the zwitterionic compound adsorbs to SiO(2) solids through the protonated N(4) in the piperazinyl group and, possibly, a cation bridge; whereas the antibiotic sorbs to Al(2)O(3) solids through the ketone and carboxylate functional groups via a ligand exchange mechanism. Sorption edge and isotherm experiments show that ofloxacin exhibits a higher affinity for mesoporous SiO(2) and nonporous Al(2)O(3), relative to their counterparts. It is hypothesized that decreased ofloxacin sorption to mesoporous Al(2)O(3) occurs due to electrostatic repulsion within pore confines. In contrast, it appears that the environment within SiO(2) mesopores promotes sorption by inducing formation of ofloxacin-Ca complexes, thus increasing electrostatic attraction to SiO(2) surfaces.
Goyne
Keith W
KW
Department of Soil, Water and Environmental Science, University of Arizona, Tucson, AZ 85721-0038, USA.
Chorover
Jon
J
Kubicki
James D
JD
Zimmerman
Andrew R
AR
Brantley
Susan L
SL
D000327:Adsorption; D000535:Aluminum / Q000737:chemistry*; D000537:Aluminum Oxide / Q000737:chemistry; D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology*; D002264:Carboxylic Acids / Q000737:chemistry; D024841:Fluoroquinolones / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D008956:Models, Chemical; D008958:Models, Molecular; D015242:Ofloxacin / Q000737:chemistry* / Q000494:pharmacology*; D012825:Silicon / Q000737:chemistry*; D012822:Silicon Dioxide / Q000737:chemistry; D013053:Spectrophotometry; D013055:Spectrophotometry, Infrared; D017550:Spectroscopy, Fourier Transform Infrared
D000900:Anti-Bacterial Agents; D002264:Carboxylic Acids; D024841:Fluoroquinolones; D012822:Silicon Dioxide; D015242:Ofloxacin; D000535:Aluminum; D000537:Aluminum Oxide; D012825:Silicon